In literature, it has been demonstrated that Scyllo-Inositol can hinder or decrease the formation of abnormal huntingtin clumps in Huntington’s disease (Lai et al., 2014) and α-synuclein plaques in Parkinson’s disease (Ibrahim and McLaurin, 2016). Here, HTT is linked to Huntington disease.